Volume | 1 385 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 4,65 | Bas Haut |
|||||
Minimum Bas | 4,62 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Aprea Therapeutics Inc | APRE | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
4,65 | 4,62 | 4,65 | 4,77 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
11 | 1 385 | US$ 4,64 | US$ 6 432 | - | 2,78 - 8,8465 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
16:04:16 | 149 | US$ 4,62 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
17,38M | 3,74M | - | 583k | -14,29M | -3,82 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Aprea Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
14/5/2024 | 14:40 | Edgar (US Regulatory) | Form 8-K - Current report |
14/5/2024 | 14:35 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06/2/2024 | 23:01 | Edgar (US Regulatory) | Form 8-K - Current report |
05/2/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
02/2/2024 | 22:26 | Edgar (US Regulatory) | Form 8-K - Current report |
26/1/2024 | 13:13 | Edgar (US Regulatory) | Form 8-K - Current report |
26/1/2024 | 12:03 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
04/1/2024 | 22:16 | Edgar (US Regulatory) | Form 8-K - Current report |
09/11/2023 | 22:20 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
09/11/2023 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report |
09/11/2023 | 22:10 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
16/10/2023 | 23:29 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Aprea Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Aprea Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 5,08 | 5,22 | 4,5001 | 4,84 | 14 083 | -0,46 | -9,06% |
1 mois | 5,25 | 5,90 | 4,5001 | 5,27 | 10 779 | -0,63 | -12,00% |
3 mois | 8,08 | 8,10 | 4,5001 | 6,41 | 31 573 | -3,46 | -42,82% |
6 mois | 3,64 | 8,8465 | 3,50 | 6,21 | 22 640 | 0,98 | 26,92% |
1 an | 3,66 | 8,8465 | 2,78 | 4,77 | 25 905 | 0,96 | 26,23% |
3 ans | 90,40 | 156,00 | 2,78 | 79,82 | 611 620 | -85,78 | -94,89% |
5 ans | 309,20 | 1 062,20 | 2,78 | 118,67 | 550 204 | -304,58 | -98,51% |